Helen Ljungdahl Round

Helen Ljungdahl Round has a BSc in Economics from Uppsala University and an MBA from the American Graduate School of International Management (Thunderbird).

Helen has more than 25 years of leadership experience in strategy, product innovation, business management, and marketing and sales in both the pharmaceutical and medical technology industry. Her career includes roles as CEO of AMNICELL, a biotech start-up based in New York City, and Senior Vice President of Global Marketing & Business Development for GN Hearing Denmark. Helen has had many international, managerial, and executive roles within Merck & Co, Inc, working in North America, the EU, the Middle East/Africa, Latin America, and Asia.